ENOB News and Press, Enochian Biosciences Inc. From 07/20/21

Enochian BioSciences (ENOB) appointed Honorable Mark Dybul, M.D. as CEO; he has served as Executive Vice-Chair of the Board since January 2019.He was a principal architect and ultimately the head of the U.S. President’s Emergency Plan for AIDS Relief; he went o...

LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Honorable Mark Dybul, M.D. has been named as Chief Executive Officer (CEO). ...

Enochian BioSciences (ENOB) shares climb more than 7% during premarket trading after announcing that the U.S. FDA has accepted a Pre-IND (Investigational New Drug) request for a potential cure of hepatitis B virus ((HBV)) infection.The Pre-IND request was made based on promising dat...

LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a...

LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioScienc...

ENOB announced on June 14, 2021, that it has entered into a 29 million registered direct offering, improving its sustainability. Its Pre-IND request for a potential HIV cure has been approved by the FDA. On June 21, 2021, the company announced that they acquired an exclusive licen...

Biotech Enochian BioSciences (NASDAQ: ENOB) enjoyed a nice share price lift on Monday. The small-cap stock rocked 12% higher at one point, although it ultimately cooled down to a 1.2% gain on the day. That morning, Enochian announced that it had acquired an exclusive license for...

MediciNova (MNOV) +52% on positive MN-166 data.Raven Industries (RAVN) +50% on being acquired by CNHI for $58.0 per share.Torchlight Energy Resources (TRCH) +39% after update on proposed business combination timing and date for preferred dividend.Hennessy Capital Investment Cor...

LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the company has acquired an exclusive license for an innovative technol...

Shares of Enochian Biosciences Inc. (NASDAQ:ENOB) traded at a new 52-week high today of $6.17. Approximately 15.1 million shares have changed hands today, as compared to an average 30-day volume of 127,000 shares. Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in ...